These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28819285)

  • 101. Inhibition of Son of Sevenless Homologue 1 (SOS1): Promising therapeutic treatment for KRAS-mutant cancers.
    Chen T; Tang X; Wang Z; Feng F; Xu C; Zhao Q; Wu Y; Sun H; Chen Y
    Eur J Med Chem; 2023 Dec; 261():115828. PubMed ID: 37778239
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Small Molecule-Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels that Are Regulated through Negative Feedback on SOS1.
    Howes JE; Akan DT; Burns MC; Rossanese OW; Waterson AG; Fesik SW
    Mol Cancer Ther; 2018 May; 17(5):1051-1060. PubMed ID: 29440291
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Discovery of Five SOS2 Fragment Hits with Binding Modes Determined by SOS2 X-Ray Cocrystallography.
    Smith CR; Chen D; Christensen JG; Coulombe R; Féthière J; Gunn RJ; Hollander J; Jones B; Ketcham JM; Khare S; Kuehler J; Lawson JD; Marx MA; Olson P; Pearson KE; Ren C; Tsagris D; Ulaganathan T; Van't Veer I; Wang X; Ivetac A
    J Med Chem; 2024 Jan; 67(1):774-781. PubMed ID: 38156904
    [TBL] [Abstract][Full Text] [Related]  

  • 104. RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth.
    Depeille P; Henricks LM; van de Ven RA; Lemmens E; Wang CY; Matli M; Werb Z; Haigis KM; Donner D; Warren R; Roose JP
    Nat Cell Biol; 2015 Jun; 17(6):804-15. PubMed ID: 26005835
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Targeting RAS oncogenesis with SOS1 inhibitors.
    Hillig RC; Bader B
    Adv Cancer Res; 2022; 153():169-203. PubMed ID: 35101230
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Design, synthesis and biological evaluation of quinazoline SOS1 inhibitors.
    Jiang H; Fan Y; Wang X; Wang J; Yang H; Fan W; Tang C
    Bioorg Med Chem Lett; 2023 May; 88():129265. PubMed ID: 37011767
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Development of Son of Sevenless Homologue 1 (SOS1) Modulators To Treat Cancers by Regulating RAS Signaling.
    Luo G; Wang B; Hou Q; Wu X
    J Med Chem; 2023 Apr; 66(7):4324-4341. PubMed ID: 36987571
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Nanobody Loop Mimetics Enhance Son of Sevenless 1-Catalyzed Nucleotide Exchange on RAS.
    Van Holsbeeck K; Fischer B; Gonzalez S; Gadais C; Versées W; Martins JC; Martin C; Wohlkönig A; Steyaert J; Ballet S
    Angew Chem Int Ed Engl; 2023 Jun; 62(24):e202219095. PubMed ID: 37067463
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Targeting of SOS1: from SOS1 Activators to Proteolysis Targeting Chimeras.
    Hamilton G; Stickler S; Rath B
    Curr Pharm Des; 2023; 29(22):1741-1746. PubMed ID: 37073657
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Discovery of Aminopiperidine Indoles That Activate the Guanine Nucleotide Exchange Factor SOS1 and Modulate RAS Signaling.
    Abbott JR; Hodges TR; Daniels RN; Patel PA; Kennedy JP; Howes JE; Akan DT; Burns MC; Sai J; Sobolik T; Beesetty Y; Lee T; Rossanese OW; Phan J; Waterson AG; Fesik SW
    J Med Chem; 2018 Jul; 61(14):6002-6017. PubMed ID: 29856609
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Design and Discovery of MRTX0902, a Potent, Selective, Brain-Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein-Protein Interaction.
    Ketcham JM; Haling J; Khare S; Bowcut V; Briere DM; Burns AC; Gunn RJ; Ivetac A; Kuehler J; Kulyk S; Laguer J; Lawson JD; Moya K; Nguyen N; Rahbaek L; Saechao B; Smith CR; Sudhakar N; Thomas NC; Vegar L; Vanderpool D; Wang X; Yan L; Olson P; Christensen JG; Marx MA
    J Med Chem; 2022 Jul; 65(14):9678-9690. PubMed ID: 35833726
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Impaired DNA replication within progenitor cell pools promotes leukemogenesis.
    Bilousova G; Marusyk A; Porter CC; Cardiff RD; DeGregori J
    PLoS Biol; 2005 Dec; 3(12):e401. PubMed ID: 16277552
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism, and redox homeostasis.
    García-Navas R; Liceras-Boillos P; Gómez C; Baltanás FC; Calzada N; Nuevo-Tapioles C; Cuezva JM; Santos E
    Oncogene; 2021 Jul; 40(27):4538-4551. PubMed ID: 34120142
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Discovery of Orally Bioavailable SOS1 Inhibitors for Suppressing KRAS-Driven Carcinoma.
    He H; Zhang Y; Xu J; Li Y; Fang H; Liu Y; Zhang S
    J Med Chem; 2022 Oct; 65(19):13158-13171. PubMed ID: 36173339
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Discovery of Potent SOS1 PROTACs with Effective Antitumor Activities against NCI-H358 Tumor Cells In Vitro/In Vivo.
    Pang X; Cui D; Lv B; Wang CY
    J Med Chem; 2024 Jan; 67(2):1563-1579. PubMed ID: 38206836
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Son of sevenless 1 (SOS1), the RasGEF, interacts with ERα and STAT3 during embryo implantation.
    Padmanabhan RA; Zyju DP; Subramaniam AG; Nautiyal J; Laloraya M
    J Mol Endocrinol; 2023 Jan; 70(1):. PubMed ID: 36103132
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Design and Structural Optimization of Orally Bioavailable SOS1 Inhibitors for the Treatment of KRAS-Driven Carcinoma.
    Zhang S; Zhang Y; Chen X; Xu J; Fang H; Li Y; Liu Y; He H
    J Med Chem; 2022 Dec; 65(23):15856-15877. PubMed ID: 36384290
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Current advances and development strategies of targeting son of sevenless 1 (SOS1) in drug discovery.
    Wu J; Li X; Wu C; Wang Y; Zhang J
    Eur J Med Chem; 2024 Mar; 268():116282. PubMed ID: 38430853
    [TBL] [Abstract][Full Text] [Related]  

  • 119. FMNL1 promotes proliferation and migration of leukemia cells.
    Favaro P; Traina F; Machado-Neto JA; Lazarini M; Lopes MR; Pereira JK; Costa FF; Infante E; Ridley AJ; Saad ST
    J Leukoc Biol; 2013 Sep; 94(3):503-12. PubMed ID: 23801653
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Studying early structural changes in SOS1 mediated KRAS activation mechanism.
    Bhadhadhara K; Jani V; Koulgi S; Sonavane U; Joshi R
    Curr Res Struct Biol; 2024; 7():100115. PubMed ID: 38188543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.